Rep. Brad Wenstrup (R-Ohio.) criticized the Biden administration’s health care policies on Friday at a House Ways and Means Committee hearing.
“If we turn over the intellectual property of a pharmaceutical or vaccine to another country that doesn’t produce it with the same quality, as we’ve seen from China … we have a problem,” Wenstrup said.
